All News

Pts will achieve LESS remission in RA, PsA & SpA if high pain catastrophizing score ~50% less remission in RA, even less in PsA (but not stat signif in PsA) ~75% less in axSpA. OP0089 @RheumNow @eular_org #EULAR2021

Janet Pope Janetbirdope ( View Tweet)

Rx of lupus nephritis in 2022 should have LESS prednisone, MMF + one of #voclosporin or #belimumab or #obinutizumab or #tacrolimus etc. Combine #MMF with another immunesuppressant for better outcomes #EULAR2021 @RheumNow @eular_org Voclosporin sustained benefit at 2 yrs POS0681

Janet Pope Janetbirdope ( View Tweet)

tyk2 makes sense to inhibit in PsA. Part of kinase family including JAK/TYK2, TYK2 is ⬆️in PsA. Deficiency of TYK2 gives less autoimmune diseases. @RheumNow @eular_org #EULAR2021 BMS Tyk Talk symposium https://t.co/knP9n0Qc0u

Janet Pope Janetbirdope ( View Tweet)
@KDAO2011 animal support is crucial to #EULAR2021 learning! https://t.co/Y1OalGcU6c
Robert B Chao, MD doctorRBC ( View Tweet)
@ARD_BMJ @alessia_alunno Retrospective picture from Friday evening replacing and in honour of the #EULAR2021 congress dinner. https://t.co/jzPp1s2SZD
Paul Studenic Stiddyo ( View Tweet)
Our Final poll results from #EULAR2021 are out. Landslide victory for #ANA to not be routinely monitored in patients treated with #TNF inhibitors or only checked when features of SLE are present @RheumNow https://t.co/4AGxHGPkco

Links:

Md Yuzaiful Md Yusof Yuz6Yusof ( View Tweet)

?Counter intuitive to have ⬇️autoimmune conditions in Sero+ RA vs seronegative but could be due to other genes that are more common in seronegative ex TNF promoter gene, PTPN22 CARD15, STAT4 etc that cluster with IBD, DMType1 etc & not shared epitope POS0313 #EULAR2021 @RheumNow https://t.co/eqLCTIU7A7

Links:

Janet Pope Janetbirdope ( View Tweet)

You get more general autoimmune disease in seropos RA, right? Not compared to seroneg RA, as it so happens (incidence and point prevalence). If anything, it leans the other way - what number of things is seroneg RA, anyway? DANBIO data POS0313 #EULAR2021 @RheumNow https://t.co/mKJQ2jjCU4
David Liew drdavidliew ( View Tweet)
Video: Psoriatic Arthritis Highlights from #EULAR2021 Dr. Jack Cush https://t.co/xedmiZKOd5 https://t.co/AShEze5rFy

Links:

Dr. John Cush RheumNow ( View Tweet)
Find our #EULAR2021 psoriatic arthritis coverage in one place. https://t.co/NzB2e2Vfwb https://t.co/P8TfUxfA3F

Links:

Dr. John Cush RheumNow ( View Tweet)
Dr. Jack Cush reviews highlight presentations from Virtual #EULAR2021. https://t.co/yjId7QNRRR

Links:

Dr. John Cush RheumNow ( View Tweet)

Novel TYK2 Inhibitor Efficacious for Treatment of Psoriatic Arthritis by Dr. Meral K El Ramahi (@MeralElRamahiMD ) #EULAR2021 https://t.co/l6YnJvuPdi

Links:

Dr. John Cush RheumNow ( View Tweet)

RheumNow’s expanded coverage of the #EULAR2021 Annual meeting is sponsored in part by Novartis, Bristol Myers Squibb, and Janssen. All content chosen by RheumNow & its faculty.

Dr. John Cush RheumNow ( View Tweet)

Video: Personalization of PsA Treatment: Dr. Robert Chao (@doctorRBC ) #EULAR2021 https://t.co/7FmZ4BzHwp

Links:

Dr. John Cush RheumNow ( View Tweet)

Combination vs. Sequential Therapy for the Treatment of Lupus Nephritis by Dr. Kathryn Dao ( @KDAO2011 ) #EULAR2021 https://t.co/0d1bxBlUS0

Links:

Dr. John Cush RheumNow ( View Tweet)

Video: How Can We Help our Patients with Sjogren's? Dr. Janet Pope (@Janetbirdope ) #EULAR2021 https://t.co/dHIrEBs1Rc

Links:

Dr. John Cush RheumNow ( View Tweet)

Artificial intelligence brings clarity to early bony changes in inflammatory arthritis by Dr. David Liew https://t.co/RPH3k2Gz0W #EULAR2021

Links:

Dr. John Cush RheumNow ( View Tweet)

RheumNow’s expanded coverage of the #EULAR2021 Annual meeting is sponsored in part by Novartis, Bristol Myers Squibb, & Janssen. All content chosen by RheumNow and its Faculty.

Dr. John Cush RheumNow ( View Tweet)

POS0192 BL prognostic factors of achieving MDA in 77 early PsA treated #T2T strategy. See forest plot below. Rather sobering results. It seems nearly fullfilling MDA at baseline is associated with fullfilling MDA at 12 months. More useful predictors needed #EULAR2021 @RheumNow https://t.co/7U65Nt3Woj
Paul Studenic Stiddyo ( View Tweet)
How common is #burnout among rheumatologists? Dr Maldonado surveyed N=297 in Latin America using Maslach Burnout Inventory. 57% had burnout. Associated with younger,long hours,⬇️satisfaction, depression,⬇️wage,comorbidities. Let's support each other #EULAR2021 #POS0302 @RheumNow https://t.co/QOA2xsDZen
Md Yuzaiful Md Yusof Yuz6Yusof ( View Tweet)
×